nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0798	0.165	CbGbCtD
Triazolam—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0734	0.152	CbGbCtD
Triazolam—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0734	0.152	CbGbCtD
Triazolam—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0564	0.117	CbGbCtD
Triazolam—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0557	0.115	CbGbCtD
Triazolam—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0381	0.0789	CbGbCtD
Triazolam—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0363	0.0753	CbGbCtD
Triazolam—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0324	0.0671	CbGbCtD
Triazolam—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.019	0.0394	CbGbCtD
Triazolam—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0179	0.0372	CbGbCtD
Triazolam—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00124	0.0034	CcSEcCtD
Triazolam—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00123	0.00338	CcSEcCtD
Triazolam—Memory impairment—Prednisone—chronic obstructive pulmonary disease	0.00123	0.00336	CcSEcCtD
Triazolam—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00328	CcSEcCtD
Triazolam—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00119	0.00326	CcSEcCtD
Triazolam—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.00325	CcSEcCtD
Triazolam—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.00118	0.00324	CcSEcCtD
Triazolam—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.00324	CcSEcCtD
Triazolam—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.00322	CcSEcCtD
Triazolam—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.0032	CcSEcCtD
Triazolam—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00116	0.00319	CcSEcCtD
Triazolam—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00313	CcSEcCtD
Triazolam—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.00114	0.00311	CcSEcCtD
Triazolam—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00114	0.00311	CcSEcCtD
Triazolam—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.00309	CcSEcCtD
Triazolam—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00309	CcSEcCtD
Triazolam—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00112	0.00306	CcSEcCtD
Triazolam—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00302	CcSEcCtD
Triazolam—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.00299	CcSEcCtD
Triazolam—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00299	CcSEcCtD
Triazolam—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00108	0.00296	CcSEcCtD
Triazolam—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00296	CcSEcCtD
Triazolam—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00296	CcSEcCtD
Triazolam—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00108	0.00295	CcSEcCtD
Triazolam—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00106	0.00291	CcSEcCtD
Triazolam—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00106	0.00289	CcSEcCtD
Triazolam—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00287	CcSEcCtD
Triazolam—Tension—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00287	CcSEcCtD
Triazolam—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00287	CcSEcCtD
Triazolam—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00287	CcSEcCtD
Triazolam—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00284	CcSEcCtD
Triazolam—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00284	CcSEcCtD
Triazolam—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.00284	CcSEcCtD
Triazolam—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00281	CcSEcCtD
Triazolam—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00281	CcSEcCtD
Triazolam—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.0028	CcSEcCtD
Triazolam—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.00278	CcSEcCtD
Triazolam—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00276	CcSEcCtD
Triazolam—Tremor—Formoterol—chronic obstructive pulmonary disease	0.001	0.00274	CcSEcCtD
Triazolam—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.001	0.00274	CcSEcCtD
Triazolam—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000997	0.00273	CcSEcCtD
Triazolam—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000995	0.00272	CcSEcCtD
Triazolam—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000992	0.00272	CcSEcCtD
Triazolam—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000992	0.00272	CcSEcCtD
Triazolam—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000991	0.00271	CcSEcCtD
Triazolam—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000989	0.00271	CcSEcCtD
Triazolam—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000983	0.00269	CcSEcCtD
Triazolam—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000983	0.00269	CcSEcCtD
Triazolam—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000981	0.00269	CcSEcCtD
Triazolam—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000981	0.00268	CcSEcCtD
Triazolam—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000978	0.00268	CcSEcCtD
Triazolam—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000971	0.00266	CcSEcCtD
Triazolam—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000971	0.00266	CcSEcCtD
Triazolam—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000964	0.00264	CcSEcCtD
Triazolam—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000964	0.00264	CcSEcCtD
Triazolam—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000962	0.00263	CcSEcCtD
Triazolam—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000962	0.00263	CcSEcCtD
Triazolam—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000946	0.00259	CcSEcCtD
Triazolam—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000946	0.00259	CcSEcCtD
Triazolam—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000945	0.00259	CcSEcCtD
Triazolam—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000945	0.00259	CcSEcCtD
Triazolam—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000938	0.00257	CcSEcCtD
Triazolam—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000937	0.00256	CcSEcCtD
Triazolam—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000928	0.00254	CcSEcCtD
Triazolam—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000926	0.00253	CcSEcCtD
Triazolam—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000925	0.00253	CcSEcCtD
Triazolam—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000923	0.00253	CcSEcCtD
Triazolam—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000923	0.00253	CcSEcCtD
Triazolam—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000911	0.00249	CcSEcCtD
Triazolam—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00091	0.00249	CcSEcCtD
Triazolam—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00091	0.00249	CcSEcCtD
Triazolam—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00091	0.00249	CcSEcCtD
Triazolam—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000907	0.00248	CcSEcCtD
Triazolam—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000907	0.00248	CcSEcCtD
Triazolam—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000906	0.00248	CcSEcCtD
Triazolam—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000905	0.00248	CcSEcCtD
Triazolam—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000899	0.00246	CcSEcCtD
Triazolam—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000899	0.00246	CcSEcCtD
Triazolam—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000892	0.00244	CcSEcCtD
Triazolam—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00089	0.00244	CcSEcCtD
Triazolam—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00089	0.00244	CcSEcCtD
Triazolam—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000889	0.00243	CcSEcCtD
Triazolam—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000887	0.00243	CcSEcCtD
Triazolam—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000884	0.00242	CcSEcCtD
Triazolam—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000873	0.00239	CcSEcCtD
Triazolam—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000873	0.00239	CcSEcCtD
Triazolam—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000872	0.00239	CcSEcCtD
Triazolam—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00086	0.00235	CcSEcCtD
Triazolam—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000857	0.00234	CcSEcCtD
Triazolam—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000855	0.00234	CcSEcCtD
Triazolam—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000855	0.00234	CcSEcCtD
Triazolam—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000852	0.00233	CcSEcCtD
Triazolam—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000852	0.00233	CcSEcCtD
Triazolam—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000849	0.00232	CcSEcCtD
Triazolam—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000848	0.00232	CcSEcCtD
Triazolam—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000845	0.00231	CcSEcCtD
Triazolam—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000841	0.0023	CcSEcCtD
Triazolam—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000827	0.00226	CcSEcCtD
Triazolam—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000824	0.00226	CcSEcCtD
Triazolam—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000811	0.00222	CcSEcCtD
Triazolam—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000811	0.00222	CcSEcCtD
Triazolam—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00081	0.00222	CcSEcCtD
Triazolam—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000804	0.0022	CcSEcCtD
Triazolam—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000797	0.00218	CcSEcCtD
Triazolam—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000797	0.00218	CcSEcCtD
Triazolam—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000789	0.00216	CcSEcCtD
Triazolam—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000789	0.00216	CcSEcCtD
Triazolam—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000785	0.00215	CcSEcCtD
Triazolam—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000785	0.00215	CcSEcCtD
Triazolam—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000778	0.00213	CcSEcCtD
Triazolam—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000778	0.00213	CcSEcCtD
Triazolam—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000776	0.00212	CcSEcCtD
Triazolam—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000776	0.00212	CcSEcCtD
Triazolam—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000773	0.00212	CcSEcCtD
Triazolam—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000768	0.0021	CcSEcCtD
Triazolam—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000765	0.00209	CcSEcCtD
Triazolam—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00076	0.00208	CcSEcCtD
Triazolam—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000758	0.00208	CcSEcCtD
Triazolam—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000752	0.00206	CcSEcCtD
Triazolam—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000752	0.00206	CcSEcCtD
Triazolam—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000746	0.00204	CcSEcCtD
Triazolam—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000746	0.00204	CcSEcCtD
Triazolam—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000746	0.00204	CcSEcCtD
Triazolam—Pain—Formoterol—chronic obstructive pulmonary disease	0.000746	0.00204	CcSEcCtD
Triazolam—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000745	0.00204	CcSEcCtD
Triazolam—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000744	0.00204	CcSEcCtD
Triazolam—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00074	0.00202	CcSEcCtD
Triazolam—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000737	0.00202	CcSEcCtD
Triazolam—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000735	0.00201	CcSEcCtD
Triazolam—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000733	0.002	CcSEcCtD
Triazolam—Pain—Montelukast—chronic obstructive pulmonary disease	0.000731	0.002	CcSEcCtD
Triazolam—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000729	0.002	CcSEcCtD
Triazolam—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000722	0.00198	CcSEcCtD
Triazolam—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000719	0.00197	CcSEcCtD
Triazolam—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000719	0.00197	CcSEcCtD
Triazolam—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000718	0.00197	CcSEcCtD
Triazolam—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000716	0.00196	CcSEcCtD
Triazolam—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000715	0.00196	CcSEcCtD
Triazolam—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000714	0.00195	CcSEcCtD
Triazolam—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000714	0.00195	CcSEcCtD
Triazolam—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00071	0.00194	CcSEcCtD
Triazolam—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000705	0.00193	CcSEcCtD
Triazolam—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000705	0.00193	CcSEcCtD
Triazolam—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000699	0.00191	CcSEcCtD
Triazolam—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000699	0.00191	CcSEcCtD
Triazolam—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00069	0.00189	CcSEcCtD
Triazolam—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00069	0.00189	CcSEcCtD
Triazolam—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000688	0.00188	CcSEcCtD
Triazolam—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000687	0.00188	CcSEcCtD
Triazolam—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000681	0.00186	CcSEcCtD
Triazolam—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000681	0.00186	CcSEcCtD
Triazolam—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000679	0.00186	CcSEcCtD
Triazolam—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000677	0.00185	CcSEcCtD
Triazolam—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000676	0.00185	CcSEcCtD
Triazolam—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000674	0.00184	CcSEcCtD
Triazolam—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000667	0.00183	CcSEcCtD
Triazolam—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000662	0.00181	CcSEcCtD
Triazolam—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000651	0.00178	CcSEcCtD
Triazolam—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000643	0.00176	CcSEcCtD
Triazolam—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000643	0.00176	CcSEcCtD
Triazolam—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000642	0.00176	CcSEcCtD
Triazolam—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000641	0.00175	CcSEcCtD
Triazolam—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00063	0.00172	CcSEcCtD
Triazolam—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000626	0.00171	CcSEcCtD
Triazolam—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000626	0.00171	CcSEcCtD
Triazolam—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000617	0.00169	CcSEcCtD
Triazolam—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000617	0.00169	CcSEcCtD
Triazolam—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000616	0.00169	CcSEcCtD
Triazolam—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000613	0.00168	CcSEcCtD
Triazolam—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000607	0.00166	CcSEcCtD
Triazolam—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000605	0.00165	CcSEcCtD
Triazolam—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000597	0.00163	CcSEcCtD
Triazolam—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000597	0.00163	CcSEcCtD
Triazolam—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000591	0.00162	CcSEcCtD
Triazolam—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000588	0.00161	CcSEcCtD
Triazolam—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000585	0.0016	CcSEcCtD
Triazolam—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000583	0.0016	CcSEcCtD
Triazolam—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000579	0.00158	CcSEcCtD
Triazolam—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000577	0.00158	CcSEcCtD
Triazolam—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000577	0.00158	CcSEcCtD
Triazolam—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000565	0.00155	CcSEcCtD
Triazolam—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000564	0.00154	CcSEcCtD
Triazolam—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000555	0.00152	CcSEcCtD
Triazolam—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000555	0.00152	CcSEcCtD
Triazolam—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00055	0.0015	CcSEcCtD
Triazolam—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00055	0.0015	CcSEcCtD
Triazolam—Headache—Formoterol—chronic obstructive pulmonary disease	0.000547	0.0015	CcSEcCtD
Triazolam—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000547	0.0015	CcSEcCtD
Triazolam—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000545	0.00149	CcSEcCtD
Triazolam—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000543	0.00149	CcSEcCtD
Triazolam—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000538	0.00147	CcSEcCtD
Triazolam—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000537	0.00147	CcSEcCtD
Triazolam—Headache—Montelukast—chronic obstructive pulmonary disease	0.000535	0.00147	CcSEcCtD
Triazolam—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000524	0.00143	CcSEcCtD
Triazolam—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000522	0.00143	CcSEcCtD
Triazolam—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000519	0.00142	CcSEcCtD
Triazolam—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000519	0.00142	CcSEcCtD
Triazolam—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000518	0.00142	CcSEcCtD
Triazolam—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000518	0.00142	CcSEcCtD
Triazolam—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000516	0.00141	CcSEcCtD
Triazolam—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000509	0.00139	CcSEcCtD
Triazolam—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000508	0.00139	CcSEcCtD
Triazolam—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.0005	0.00137	CcSEcCtD
Triazolam—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000489	0.00134	CcSEcCtD
Triazolam—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000487	0.00133	CcSEcCtD
Triazolam—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000481	0.00132	CcSEcCtD
Triazolam—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000473	0.00129	CcSEcCtD
Triazolam—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000465	0.00127	CcSEcCtD
Triazolam—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000461	0.00126	CcSEcCtD
Triazolam—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000457	0.00125	CcSEcCtD
Triazolam—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000427	0.00117	CcSEcCtD
Triazolam—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000424	0.00116	CcSEcCtD
Triazolam—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000421	0.00115	CcSEcCtD
Triazolam—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000406	0.00268	CbGpPWpGaD
Triazolam—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000405	0.00268	CbGpPWpGaD
Triazolam—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000404	0.00111	CcSEcCtD
Triazolam—GABRA6—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000403	0.00266	CbGpPWpGaD
Triazolam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000402	0.00266	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.0004	0.00264	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000398	0.00263	CbGpPWpGaD
Triazolam—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00039	0.00107	CcSEcCtD
Triazolam—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00039	0.00257	CbGpPWpGaD
Triazolam—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000389	0.00107	CcSEcCtD
Triazolam—GABRA5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000389	0.00257	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000387	0.00256	CbGpPWpGaD
Triazolam—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000387	0.00106	CcSEcCtD
Triazolam—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000382	0.00252	CbGpPWpGaD
Triazolam—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000379	0.00104	CcSEcCtD
Triazolam—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000379	0.00251	CbGpPWpGaD
Triazolam—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000377	0.00103	CcSEcCtD
Triazolam—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000376	0.00248	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000375	0.00248	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000373	0.00246	CbGpPWpGaD
Triazolam—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00037	0.00245	CbGpPWpGaD
Triazolam—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00037	0.00101	CcSEcCtD
Triazolam—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000369	0.00244	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000366	0.00242	CbGpPWpGaD
Triazolam—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000364	0.0024	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000364	0.0024	CbGpPWpGaD
Triazolam—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000363	0.000994	CcSEcCtD
Triazolam—CYP2C8—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000363	0.0024	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000363	0.0024	CbGpPWpGaD
Triazolam—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000362	0.00239	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00036	0.00238	CbGpPWpGaD
Triazolam—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000359	0.00237	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000359	0.00237	CbGpPWpGaD
Triazolam—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000357	0.00236	CbGpPWpGaD
Triazolam—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000357	0.000977	CcSEcCtD
Triazolam—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000354	0.000969	CcSEcCtD
Triazolam—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000354	0.00234	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000353	0.00233	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000352	0.00233	CbGpPWpGaD
Triazolam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000352	0.00233	CbGpPWpGaD
Triazolam—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000348	0.000953	CcSEcCtD
Triazolam—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000347	0.00229	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000347	0.00229	CbGpPWpGaD
Triazolam—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000343	0.00094	CcSEcCtD
Triazolam—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000341	0.00225	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000339	0.00224	CbGpPWpGaD
Triazolam—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000338	0.00223	CbGpPWpGaD
Triazolam—Shock—Prednisone—chronic obstructive pulmonary disease	0.000338	0.000925	CcSEcCtD
Triazolam—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000335	0.000917	CcSEcCtD
Triazolam—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000333	0.0022	CbGpPWpGaD
Triazolam—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000332	0.000909	CcSEcCtD
Triazolam—GABRA6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000328	0.00217	CbGpPWpGaD
Triazolam—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000327	0.000896	CcSEcCtD
Triazolam—GABRA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000324	0.00214	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000321	0.00212	CbGpPWpGaD
Triazolam—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00032	0.00212	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00032	0.00211	CbGpPWpGaD
Triazolam—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000314	0.00207	CbGpPWpGaD
Triazolam—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000313	0.000855	CcSEcCtD
Triazolam—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000311	0.00205	CbGpPWpGaD
Triazolam—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000311	0.00085	CcSEcCtD
Triazolam—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000309	0.00204	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000309	0.00204	CbGpPWpGaD
Triazolam—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000308	0.000844	CcSEcCtD
Triazolam—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000299	0.000817	CcSEcCtD
Triazolam—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000298	0.000815	CcSEcCtD
Triazolam—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000296	0.00196	CbGpPWpGaD
Triazolam—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000296	0.00081	CcSEcCtD
Triazolam—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000296	0.00081	CcSEcCtD
Triazolam—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000295	0.00195	CbGpPWpGaD
Triazolam—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000295	0.00195	CbGpPWpGaD
Triazolam—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000295	0.00195	CbGpPWpGaD
Triazolam—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000294	0.000804	CcSEcCtD
Triazolam—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000294	0.00194	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000291	0.00192	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000288	0.0019	CbGpPWpGaD
Triazolam—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000283	0.00187	CbGpPWpGaD
Triazolam—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000283	0.000775	CcSEcCtD
Triazolam—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000283	0.00187	CbGpPWpGaD
Triazolam—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000281	0.000769	CcSEcCtD
Triazolam—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000281	0.000768	CcSEcCtD
Triazolam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00028	0.00185	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000278	0.00184	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000276	0.00182	CbGpPWpGaD
Triazolam—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000271	0.000743	CcSEcCtD
Triazolam—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000271	0.00179	CbGpPWpGaD
Triazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000265	0.00175	CbGpPWpGaD
Triazolam—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000264	0.00174	CbGpPWpGaD
Triazolam—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000263	0.00174	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000261	0.00172	CbGpPWpGaD
Triazolam—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00026	0.00171	CbGpPWpGaD
Triazolam—CYP3A7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00026	0.00171	CbGpPWpGaD
Triazolam—CYP3A7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000257	0.00169	CbGpPWpGaD
Triazolam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000255	0.00169	CbGpPWpGaD
Triazolam—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000254	0.00168	CbGpPWpGaD
Triazolam—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000253	0.000692	CcSEcCtD
Triazolam—Flunitrazepam—CYP1A2—chronic obstructive pulmonary disease	0.000252	0.29	CrCbGaD
Triazolam—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000252	0.00166	CbGpPWpGaD
Triazolam—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000246	0.000674	CcSEcCtD
Triazolam—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000665	CcSEcCtD
Triazolam—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000237	0.00157	CbGpPWpGaD
Triazolam—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000643	CcSEcCtD
Triazolam—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000228	0.0015	CbGpPWpGaD
Triazolam—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000622	CcSEcCtD
Triazolam—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000225	0.00149	CbGpPWpGaD
Triazolam—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000598	CcSEcCtD
Triazolam—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000592	CcSEcCtD
Triazolam—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000216	0.00142	CbGpPWpGaD
Triazolam—Headache—Prednisone—chronic obstructive pulmonary disease	0.000215	0.000589	CcSEcCtD
Triazolam—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000215	0.00142	CbGpPWpGaD
Triazolam—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000213	0.00141	CbGpPWpGaD
Triazolam—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000213	0.00141	CbGpPWpGaD
Triazolam—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000208	0.00138	CbGpPWpGaD
Triazolam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000207	0.00137	CbGpPWpGaD
Triazolam—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000558	CcSEcCtD
Triazolam—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000194	0.00128	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000188	0.00124	CbGpPWpGaD
Triazolam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000185	0.00122	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000185	0.00122	CbGpPWpGaD
Triazolam—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000185	0.00122	CbGpPWpGaD
Triazolam—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000183	0.00121	CbGpPWpGaD
Triazolam—Chlorprothixene—HTR2A—chronic obstructive pulmonary disease	0.000183	0.21	CrCbGaD
Triazolam—Clonazepam—ALB—chronic obstructive pulmonary disease	0.000181	0.208	CrCbGaD
Triazolam—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00018	0.00119	CbGpPWpGaD
Triazolam—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000177	0.00117	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000172	0.00114	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000172	0.00114	CbGpPWpGaD
Triazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000168	0.00111	CbGpPWpGaD
Triazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000166	0.0011	CbGpPWpGaD
Triazolam—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000165	0.00109	CbGpPWpGaD
Triazolam—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000163	0.00108	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000162	0.00107	CbGpPWpGaD
Triazolam—Diazepam—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.185	CrCbGaD
Triazolam—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000161	0.00106	CbGpPWpGaD
Triazolam—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.00104	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000156	0.00103	CbGpPWpGaD
Triazolam—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000155	0.00102	CbGpPWpGaD
Triazolam—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.00102	CbGpPWpGaD
Triazolam—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.000999	CbGpPWpGaD
Triazolam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00015	0.000993	CbGpPWpGaD
Triazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000136	0.000901	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.000892	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000133	0.00088	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000133	0.00088	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000132	0.000874	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000131	0.000863	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00013	0.000859	CbGpPWpGaD
Triazolam—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000128	0.000847	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000127	0.00084	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000127	0.00084	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000126	0.000833	CbGpPWpGaD
Triazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.000808	CbGpPWpGaD
Triazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.000797	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000119	0.000789	CbGpPWpGaD
Triazolam—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000118	0.000778	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000114	0.000754	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.000748	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000113	0.000744	CbGpPWpGaD
Triazolam—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.000738	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000111	0.000734	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.000726	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000108	0.000716	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000106	0.000702	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000105	0.000692	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000104	0.000684	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000103	0.000681	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000102	0.000674	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000102	0.000673	CbGpPWpGaD
Triazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.91e-05	0.000655	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.81e-05	0.000648	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.76e-05	0.000645	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.68e-05	0.000639	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.63e-05	0.000636	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.3e-05	0.000614	CbGpPWpGaD
Triazolam—Diazepam—ALB—chronic obstructive pulmonary disease	9.29e-05	0.107	CrCbGaD
Triazolam—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.17e-05	0.000605	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	9.11e-05	0.000602	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.04e-05	0.000597	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.81e-05	0.000582	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.72e-05	0.000576	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	8.63e-05	0.00057	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.62e-05	0.000569	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.56e-05	0.000565	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.42e-05	0.000556	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.41e-05	0.000555	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.35e-05	0.000552	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.31e-05	0.000549	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.26e-05	0.000546	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.21e-05	0.000542	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	8.12e-05	0.000537	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.06e-05	0.000532	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8e-05	0.000529	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.99e-05	0.000527	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	7.89e-05	0.000521	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.88e-05	0.00052	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.63e-05	0.000504	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.63e-05	0.000504	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.55e-05	0.000499	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	7.4e-05	0.000489	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.25e-05	0.000479	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.15e-05	0.000472	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.04e-05	0.000465	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	6.42e-05	0.000424	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.29e-05	0.000415	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.19e-05	0.000409	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.05e-05	0.000399	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.04e-05	0.000399	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.97e-05	0.000394	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.96e-05	0.000394	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	5.87e-05	0.000388	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.86e-05	0.000387	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.79e-05	0.000382	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.63e-05	0.000372	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.56e-05	0.000367	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.48e-05	0.000362	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.46e-05	0.000361	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.29e-05	0.000349	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.27e-05	0.000348	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.23e-05	0.000345	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.19e-05	0.000343	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.19e-05	0.000343	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.14e-05	0.00034	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	5.09e-05	0.000336	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.05e-05	0.000333	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.96e-05	0.000328	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.93e-05	0.000326	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.84e-05	0.00032	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.73e-05	0.000312	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.58e-05	0.000303	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.44e-05	0.000293	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	4.39e-05	0.00029	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.26e-05	0.000281	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.24e-05	0.00028	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.23e-05	0.000279	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.22e-05	0.000279	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	4.14e-05	0.000273	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	4e-05	0.000264	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.85e-05	0.000254	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.77e-05	0.000249	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.69e-05	0.000244	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.21e-05	0.000212	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	3.17e-05	0.000209	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.08e-05	0.000203	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.07e-05	0.000203	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.03e-05	0.0002	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	2.89e-05	0.000191	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.83e-05	0.000187	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.81e-05	0.000185	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.78e-05	0.000184	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.75e-05	0.000181	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.73e-05	0.00018	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.68e-05	0.000177	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.67e-05	0.000176	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.56e-05	0.000169	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.54e-05	0.000168	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.51e-05	0.000166	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.31e-05	0.000153	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.26e-05	0.000149	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.24e-05	0.000148	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.22e-05	0.000147	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.19e-05	0.000145	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.08e-05	0.000138	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.04e-05	0.000135	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.04e-05	0.000135	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.94e-05	0.000128	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.93e-05	0.000127	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.9e-05	0.000125	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.88e-05	0.000124	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.82e-05	0.00012	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.77e-05	0.000117	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.74e-05	0.000115	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.68e-05	0.000111	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.57e-05	0.000104	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.55e-05	0.000102	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.49e-05	9.85e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.47e-05	9.74e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.44e-05	9.52e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.37e-05	9.02e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.35e-05	8.89e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.32e-05	8.7e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.26e-05	8.32e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.24e-05	8.19e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.14e-05	7.53e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.09e-05	7.21e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.03e-05	6.83e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.02e-05	6.73e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.5e-06	6.28e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	9.28e-06	6.13e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.01e-06	5.95e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	8.88e-06	5.87e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.12e-06	4.04e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.86e-06	3.87e-05	CbGpPWpGaD
